Eikon Therapeutics, Inc.
4 private offerings reported to the SEC on Form D since 2016, $1.1B sold in all. Biotech, CA.
- Form D offerings: 4
- Reported sold: $1.1B
- Newest: Feb 28, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Feb 28, 2025 | $350.7M | $400.0M | Eikon Therapeutics, Inc.Biotech · CA | Not amended | 0001861123-25-000001 |
| Jun 1, 2023 | $140.8M | $535.0M | Eikon Therapeutics, Inc.Biotech · CA | Not amended | 0001861123-23-000001 |
| Jan 6, 2022 | $517.8M | $525.0M | Eikon Therapeutics, Inc.Biotech · CA | Not amended | 0001861123-22-000001 |
| May 13, 2021 | $102.5M | $107.8M | Eikon Therapeutics, Inc.Biotech · CA | Not amended | 0001861123-21-000001 |
SEC Profile
From the company's EDGAR record- Ticker
- EIKN
- Business address
- Millbrae, Ca
- Incorporated in
- DE
- SEC industry
- Biological Products, (No Diagnostic Substances)
- All SEC filings
- CIK 1861123 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR